AEterna Zentaris to Present at Upcoming Canaccord Adams Life Sciences Mini-Conference in Montreal
May 25 2006 - 12:49PM
PR Newswire (US)
QUEBEC CITY, Canada, May 25 /PRNewswire-FirstCall/ -- AEterna
Zentaris Inc. (TSX: AEZ; Nasdaq: AEZS) today announced that Gilles
Gagnon, President and Chief Executive Officer of the Company, will
present a corporate update at the Canaccord Adams Life Sciences
Mini-Conference: Drug Developers, on Wednesday, May 31, 2006, at
1:30 p.m. (local time), at the University Club in Montreal. About
AEterna Zentaris Inc. AEterna Zentaris Inc. is a growing global
biopharmaceutical company engaged in the discovery, development and
marketing of therapies for cancer and endocrine disorders. AEterna
Zentaris also owns 48.29% of the equity of Atrium Biotechnologies
Inc. (TSX: ATB.sv) and 64.7% of its voting rights. Atrium is a
developer, manufacturer and marketer of science-based products for
the cosmetics, pharmaceutical, chemical and nutritional industries.
News releases and additional information are available at
http://www.aeternazentaris.com/. DATASOURCE: AETERNA ZENTARIS INC.
(FORMERLY/ANCIENNEMENT - LES LABORATOIRES AETERNA CONTACT: Media
Relations: Paul Burroughs, (418) 652-8525 ext. 406, ; Investor
Relations: Jenene Thomas, (418) 655-6420 or (908) 996-3154, ; To
request a free copy of this organization's annual report, please go
to http://www.newswire.ca/ and click on reports@cnw.
Copyright